
About BTS Bioengineering
BTS Bioengineering is a Healthcare company based in Garbagnate Milanese (Italy) founded in 1986. It operates as a motion capture systems are supplied for sports and healthcare applications. Its website btsbioengineering.com draws about 15 thousand monthly visits. BTS Bioengineering offers products and services including SMART-DX, EVO, FREEEMG, G-WALK, and BTS GAITLAB. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its legal entity is BTS S.p.A. Its competitors include Blackrock Neurotech, Nexstim, MindMaze, Precision Neuroscience and INBRAIN Neuroelectronics and 4 more; 8 of its 9 listed competitors have raised funding.
Company details
Founded in 1986 in Garbagnate Milanese, Italy, operations in bioengineering focus on motion capture technology for sports and healthcare sectors. Integrated tools are developed for motor and neurological rehabilitation among adults and children. Systems for motion analysis are applied to support athlete performance. Key areas encompass gait and posture evaluation, sport biomechanics, ergonomics, and programs for cognitive rehabilitation, mobility, injury prevention, and return-to-play protocols.
- Headquarters Garbagnate Milanese, Italy
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website btsbioengineering.com
- Social LinkedIn X Facebook YouTube
- Legal Name Bts S.P.A.
- Latest Funding Round$144.6K (USD), Grant
Feb 2021
- Investors
Products & Services of BTS Bioengineering
BTS Bioengineering offers a comprehensive portfolio of products and services, including SMART-DX, EVO, FREEEMG, G-WALK, and BTS GAITLAB.
Captures human body movements for engineering and research applications.
Supports motion analysis in medical and sports contexts.
Evaluates muscle activity for rehabilitation and performance.
Assesses walking patterns in clinical and sports settings.
Provides comprehensive gait evaluation for medical diagnostics.
Apps and channels of BTS Bioengineering
its YouTube channel BTS Bioengineering has 1.74K subscribers and 30 videos.
Videos from BTS Bioengineering
The most watched videos on BTS Bioengineering's YouTube channel, BTS Bioengineering (1.74K subscribers). Click a video to play it here.
More on BTS Bioengineering.
Funding Insights of BTS Bioengineering
- Total Rounds 1
- Last Round Grant β $144,599
- First Round $144,599
(Feb 2021)
- Investors Count 1
All 1 funding rounds of BTS Bioengineering with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2021 | $144,599 | Grant | β | β |
1 investors in total: 1 institutional.
Investors in BTS Bioengineering
BTS Bioengineering has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for BTS Bioengineering
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of BTS Bioengineering
2 dated milestones of BTS Bioengineering across 35 years, from founding to its latest funding, stage changes and deals.
- Founded BTS Bioengineering is founded.
- Funding First funding round of $145K.
Competitors of BTS Bioengineering
BTS Bioengineering has 9 listed competitors in our database, 8 of them funded. They include Blackrock Neurotech, Nexstim, MindMaze, Precision Neuroscience and INBRAIN Neuroelectronics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| blackrockneurotech.com | 2008 | Salt Lake, United States | $22.37M | 127 | Medical devices for neurological therapies are developed. | |
| nexstim.com | 2000 | Helsinki, Finland | $29.67M | – | Noninvasive brain stimulation is provided for stroke patient rehabilitation. | |
| mindmaze.com | 2012 | Lausanne, Switzerland | $223.5M | – | Evidence-based digital neurotherapeutics are developed for brain health recovery. | |
| precisionneuro.io | 2021 | New York, United States | $182.65M | 22 | Brain-computer interfaces developed for medical treatment and drug development. | |
| inbrain-neuroelectronics.com | 2019 | Barcelona, Spain | $82.84M | – | AI-based neuroelectronic devices for brain disorder detection are developed. | |
| synergia-medical.com | 2013 | Mont Saint Guibert, Belgium | $14.16M | 18 | Implantable neurostimulators and contactless monitoring systems are developed. | |
| endonovo.com | 2011 | Los Angeles, United States | – | – | Bioelectronic devices are developed for regenerative medicine therapies. | |
| minnetronixmedical.com | 1996 | Saint Paul, United States | $20M | 263 | Multiple devices for neurocritical patients are manufactured and developed. | |
| heliusmedical.com | 2014 | Newtown Square, United States | $391,092 | 26 | Neurological rehabilitation devices are developed for brain healing amplification. |
Detailed competitors of BTS Bioengineering
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BTS Bioengineering
The website of BTS Bioengineering (btsbioengineering.com) receives about 15.5K visits a month.
- Monthly visits15.5K
▲ 22.2% vs previous month
Websites whose visitors overlap most with BTS Bioengineering. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ergoline.com | 100% | 2.7K | #5,868,269 | View details | |
| fda.gov | 86% | – | #7,606 | View details | |
cosmed.it | cosmed.it | 66% | – | – | β |
| c-motion.com | 37% | – | – | View details | |
basketballtrainer.com | basketballtrainer.com | 32% | – | #15,234,237 | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 7 similar websites and full traffic analytics for BTS Bioengineering
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Neurology
10 companies that operate in the same segment as BTS Bioengineering (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | – | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BTS Bioengineering
BTS Bioengineering was founded in 1986 and raised its 1st funding round 35 years after it was founded.
BTS Bioengineering is headquartered in Garbagnate Milanese, Italy. It is registered at Garbagnate Milanese, Lombardy, Italy.
Founded in 1986 in Garbagnate Milanese, Italy, operations in bioengineering focus on motion capture technology for sports and healthcare sectors. Integrated tools are developed for motor and neurological rehabilitation among adults and children. Systems for motion analysis are applied to support athlete performance. Key areas encompass gait and posture evaluation, sport biomechanics, ergonomics, and programs for cognitive rehabilitation, mobility, injury prevention, and return-to-play protocols.
BTS Bioengineering's top competitors include Blackrock Neurotech, Precision Neuroscience and INBRAIN Neuroelectronics.
BTS Bioengineering offers SMART-DX, EVO, FREEEMG, G-WALK, and BTS GAITLAB.
BTS Bioengineering has 1 investor. Key investors include European Union.
BTS Bioengineering operates through Bts S.P.A..